Reassessment of the risks of climate change for terrestrial ecosystems

Forecasting the risks of climate change for species and ecosystems is necessary for developing targeted conservation strategies. Previous risk assessments mapped the exposure of the global land surface to changes in climate. However, this procedure is unlikely to robustly identify priority areas for conservation actions because nonlinear physiological responses and colimitation processes ensure that ecological changes will not map perfectly to the forecast climatic changes. Here, we combine ecophysiological growth models of 135,153 vascular plant species and plant growth-form information to transform ambient and future climatologies into phytoclimates, which describe the ability of climates to support the plant growth forms that characterize terrestrial ecosystems. We forecast that 33% to 68% of the global land surface will experience a significant change in phytoclimate by 2070 under representative concentration pathways RCP 2.6 and RCP 8.5, respectively. Phytoclimates without present-day analogue are forecast to emerge on 0.3–2.2% of the land surface and 0.1–1.3% of currently realized phytoclimates are forecast to disappear. Notably, the geographic pattern of change, disappearance and novelty of phytoclimates differs markedly from the pattern of analogous trends in climates detected by previous studies, thereby defining new priorities for conservation actions and highlighting the limits of using untransformed climate change exposure indices in ecological risk assessments. Our findings suggest that a profound transformation of the biosphere is underway and emphasize the need for a timely adaptation of biodiversity management practices.

Randomization Describe how samples/organisms/participants were allocated into experimental groups.If allocation was not random, describe how covariates were controlled OR if this is not relevant to your study, explain why.

Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.If blinding was not possible, describe why OR explain why blinding was not relevant to your study.

Behavioural & social sciences study design
All studies must disclose on these points even when the disclosure is negative.

Study description
Briefly describe the study type including whether data are quantitative, qualitative, or mixed-methods (e.g.qualitative cross-sectional, quantitative experimental, mixed-methods case study).

Research sample
State the research sample (e.g.Harvard university undergraduates, villagers in rural India) and provide relevant demographic information (e.g.age, sex) and indicate whether the sample is representative.Provide a rationale for the study sample chosen.For studies involving existing datasets, please describe the dataset and source.

Sampling strategy
Describe the sampling procedure (e.g. random, snowball, stratified, convenience).Describe the statistical methods that were used to predetermine sample size OR if no sample-size calculation was performed, describe how sample sizes were chosen and provide a rationale for why these sample sizes are sufficient.For qualitative data, please indicate whether data saturation was considered, and what criteria were used to decide that no further sampling was needed.

Data collection
Provide details about the data collection procedure, including the instruments or devices used to record the data (e.g.pen and paper, computer, eye tracker, video or audio equipment) whether anyone was present besides the participant(s) and the researcher, and whether the researcher was blind to experimental condition and/or the study hypothesis during data collection.

Timing
Indicate the start and stop dates of data collection.If there is a gap between collection periods, state the dates for each sample cohort.Field-collected samples For laboratory work with field-collected samples, describe all relevant parameters such as housing, maintenance, temperature, photoperiod and end-of-experiment protocol OR state that the study did not involve samples collected from the field.

nature portfolio | reporting summary
April 2023

Design type
Indicate task or resting state; event-related or block design.

Specify the number of blocks, trials or experimental units per session and/or subject, and specify the length of each trial or block (if trials are blocked) and interval between trials.
Behavioral performance measures State number and/or type of variables recorded (e.g.correct button press, response time) and what statistics were used to establish that the subjects were performing the task as expected (e.g.mean, range, and/or standard deviation across subjects).

Specify in Tesla
Sequence & imaging parameters Specify the pulse sequence type (gradient echo, spin echo, etc.), imaging type (EPI, spiral, etc.), field of view, matrix size, slice thickness, orientation and TE/TR/flip angle.

Area of acquisition
State whether a whole brain scan was used OR define the area of acquisition, describing how the region was determined.

Diffusion MRI
Used Not used

Preprocessing
Preprocessing software Provide detail on software version and revision number and on specific parameters (model/functions, brain extraction, segmentation, smoothing kernel size, etc.).

Normalization
If data were normalized/standardized, describe the approach(es): specify linear or non-linear and define image types used for transformation OR indicate that data were not normalized and explain rationale for lack of normalization.

Normalization template
Describe the template used for normalization/transformation, specifying subject space or group standardized space (e.g.original Talairach, MNI305, ICBM152) OR indicate that the data were not normalized.

Noise and artifact removal
Describe your procedure(s) for artifact and structured noise removal, specifying motion parameters, tissue signals and physiological signals (heart rate, respiration).

Volume censoring
Define your software and/or method and criteria for volume censoring, and state the extent of such censoring.

Statistical modeling & inference
Model type and settings Specify type (mass univariate, multivariate, RSA, predictive, etc.) and describe essential details of the model at the first and second levels (e.g.fixed, random or mixed effects; drift or auto-correlation).

Graph analysis
Report the dependent variable and connectivity measure, specifying weighted graph or binarized graph, Describe all antibodies used in the study; as applicable, provide supplier name, catalog number, clone name, and lot number.April 2023 numbers in this Reporting Summary.Please state if this information has not been collected.Report sex-based analyses where performed, justify reasons for lack of sex-based analysis.
Define precise effect in terms of the task or stimulus conditions instead of psychological concepts and indicate whether ANOVA or factorial designs were used.CorrectionDescribe the type of correction and how it is obtained for multiple comparisons (e.g.FWE, FDR, permutation or Monte Carlo).
Report the measures of dependence used and the model details (e.g.Pearson correlation, partial correlation, mutual information).